Revere Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Pharmaceutical ETF
PPH
|
+$15.1M |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$11.2M |
| 3 |
Tesla
TSLA
|
+$10.4M |
| 4 |
DoorDash
DASH
|
+$9M |
| 5 |
MP Materials
MP
|
+$8.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spotify
SPOT
|
+$17.4M |
| 2 |
GE Vernova
GEV
|
+$12.6M |
| 3 |
Apple
AAPL
|
+$8.27M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$7.37M |
| 5 |
NBIS
Nebius Group N.V.
NBIS
|
+$2.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 65% |
| 2 | Technology | 13.69% |
| 3 | Consumer Discretionary | 9.05% |
| 4 | Financials | 4.69% |
| 5 | Materials | 3.23% |
Similar funds
Revere Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, Revere Asset Management held 44 positions worth $265M, up 29% from $206M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Revere Asset Management deployed $21.4M of net new capital in Q3 2025, opening 19 new positions and adding to 9 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 172,958 shares worth $15.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, up from 65% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $8.27M trimmed.
- Revere Asset Management's largest Q3 2025 buy was VanEck Pharmaceutical ETF: 172,958 shares worth $15.6M.
- Revere Asset Management added most to State Street SPDR Portfolio S&P 500 ETF in Q3 2025, an estimated $11.2M increase.
- Revere Asset Management's biggest Q3 2025 reduction was Apple, cutting an estimated $8.27M.
- Revere Asset Management fully exited Spotify in Q3 2025, selling an estimated $17.4M.
- Revere Asset Management's ten largest holdings make up 85% of its $265M portfolio in Q3 2025.
- Revere Asset Management opened 19 new positions and closed 9 in Q3 2025.
- Revere Asset Management's portfolio value rose 29% quarter-over-quarter to $265M.
Based on Revere Asset Management's 13F filing for Q3 2025, filed 17 Nov 2025.